Potential therapeutic targets to improve the prognosis of patients with acute erythroid leukemia

Описание к видео Potential therapeutic targets to improve the prognosis of patients with acute erythroid leukemia

Ilaria Iacobucci, PhD, St. Jude Children's Research Hospital, Memphis, TN, comments on the challenges of treating acute erythroid leukemia, a subtype of leukemia characterized by a lack of well-known therapeutic targets and poor prognostic outcomes. Dr Iacobucci highlights the potential of targeting the BCL2L1 gene and identifies the heme biosynthesis pathway as a promising target for therapeutic intervention. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Комментарии

Информация по комментариям в разработке

Похожие видео